Sufentanil 5 Μg/Ml 2 Ml Viatris And Sufentanil 5 Μg/Ml 10 Ml Viatris 5 μg/ml 2 ml AND 5 μg/ml 10 ml Solution for injection
PDF Leaflet Revision Date: 10 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Analgesic adjunct in general anaesthesia and postoperative pain management.
Dosage (summary)
IV: 1-8 u03bcg/kg initial; 0.1-0.5 u03bcg/kg maintenance. Epidural: 30-50 u03bcg for 4-6 hours.
Onset of Action / Duration
Onset: Rapid, Duration: 1-8 hours
Special Populations
- Elderly
- Renal impairment
- Paediatric patients
Pregnancy & Breastfeeding
Safety not established; contraindicated IV in labor; monitor breastfeeding infants.
Key Drug Interactions
- CNS depressants
- Benzodiazepines
- MAO inhibitors
Contraindications
- Known intolerance to sufentanil or opioids
- IV use in labor
- Severe hemorrhage or shock
Common side effects
- Respiratory depression
- Hypotension
- Nausea
Counselling Points
- Avoid driving for 24 hours post-administration
- Monitor for signs of respiratory depression
- Do not breastfeed for 12-24 hours post-dose
Serious warnings
- Risk of respiratory depression
- Monitor vital signs continuously
- Caution in patients with compromised respiratory function
Important Disclaimer
The Sufentanil 5 Μg/Ml 2 Ml Viatris And Sufentanil 5 Μg/Ml 10 Ml Viatris 5 μg/ml 2 ml AND 5 μg/ml 10 ml Solution for injection professional information leaflet below is the property of Viatris South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
